JP2024012470A5 - - Google Patents

Download PDF

Info

Publication number
JP2024012470A5
JP2024012470A5 JP2023187803A JP2023187803A JP2024012470A5 JP 2024012470 A5 JP2024012470 A5 JP 2024012470A5 JP 2023187803 A JP2023187803 A JP 2023187803A JP 2023187803 A JP2023187803 A JP 2023187803A JP 2024012470 A5 JP2024012470 A5 JP 2024012470A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
adam10
peptide
positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023187803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024012470A (ja
Filing date
Publication date
Priority claimed from JP2020520057A external-priority patent/JP7448219B2/ja
Application filed filed Critical
Publication of JP2024012470A publication Critical patent/JP2024012470A/ja
Publication of JP2024012470A5 publication Critical patent/JP2024012470A5/ja
Pending legal-status Critical Current

Links

JP2023187803A 2017-10-02 2023-11-01 Adam10の生物学的活性を阻害するための方法および組成物 Pending JP2024012470A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762566580P 2017-10-02 2017-10-02
US62/566,580 2017-10-02
US201762589842P 2017-11-22 2017-11-22
US62/589,842 2017-11-22
JP2020520057A JP7448219B2 (ja) 2017-10-02 2018-10-02 Adam10の生物学的活性を阻害するための方法および組成物
PCT/US2018/053938 WO2019070685A1 (en) 2017-10-02 2018-10-02 METHODS AND COMPOSITIONS FOR INHIBITING BIOLOGICAL ACTIVITIES OF ADAM10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020520057A Division JP7448219B2 (ja) 2017-10-02 2018-10-02 Adam10の生物学的活性を阻害するための方法および組成物

Publications (2)

Publication Number Publication Date
JP2024012470A JP2024012470A (ja) 2024-01-30
JP2024012470A5 true JP2024012470A5 (https=) 2024-06-04

Family

ID=65995419

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020520057A Active JP7448219B2 (ja) 2017-10-02 2018-10-02 Adam10の生物学的活性を阻害するための方法および組成物
JP2023187803A Pending JP2024012470A (ja) 2017-10-02 2023-11-01 Adam10の生物学的活性を阻害するための方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020520057A Active JP7448219B2 (ja) 2017-10-02 2018-10-02 Adam10の生物学的活性を阻害するための方法および組成物

Country Status (8)

Country Link
US (3) US20190345473A1 (https=)
EP (1) EP3691671A4 (https=)
JP (2) JP7448219B2 (https=)
AU (1) AU2018345601B2 (https=)
CA (1) CA3077694A1 (https=)
IL (1) IL273725A (https=)
MX (1) MX2020004218A (https=)
WO (1) WO2019070685A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3094136A1 (en) 2018-01-31 2019-08-08 Verra Therapeutics LLC Methods and compositions for inhibiting adam9 biological activities
WO2020227714A1 (en) * 2019-05-09 2020-11-12 Verra Therapeutics, Llc Methods and compositions for inhibiting adam8 biological activities
JP2025507975A (ja) * 2022-03-08 2025-03-21 ノバ サウスイースタン ユニバーシティー ディスインテグリンおよびメタロプロテアーゼ10(adam10)の酵素・基質選択的エキソサイト阻害剤を用いた関節リウマチ(ra)の処置方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024089A2 (en) 2002-09-11 2004-03-25 Sloan-Kettering Institute For Cancer Research Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing
AU2004240630B2 (en) * 2003-05-15 2010-10-07 Trustees Of Tufts College Stable analogs of peptide and polypeptide therapeutics
AU2006210589B2 (en) 2005-02-02 2011-12-08 Macrogenics West, Inc. ADAM-9 modulators
EP1896580A2 (en) 2005-04-07 2008-03-12 Novartis Vaccines and Diagnostics, Inc. Adam10 in cancer diagnosis, detection and treatment
US7638301B2 (en) * 2006-08-28 2009-12-29 Biozyme, Inc. Prodomain modulators of ADAM 10
US20090285840A1 (en) 2008-04-29 2009-11-19 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Methods for treating pathological neovascularization
US8079782B1 (en) 2008-05-16 2011-12-20 Hilfiker William K Semi-extensible steel soil reinforcements for mechanically stabilized embankments
US9150865B2 (en) 2010-11-09 2015-10-06 The University Of Chicago Role of ADAM10 and its relevance to disease and therapeutics
WO2012088105A2 (en) * 2010-12-20 2012-06-28 Biozyme Inc. Methods and compositions for predicting disease status in cancer
AU2015213481A1 (en) 2014-02-04 2016-08-25 Ludwig Institute For Cancer Research Ltd Anti-Metalloprotease antibody for diagnosis and treatment of cancers

Similar Documents

Publication Publication Date Title
JP2024012470A5 (https=)
ES2393373T3 (es) Método para la producción de factor-I de crecimiento similar a la insulina
Uppalapati et al. A potent D-protein antagonist of VEGF-A is nonimmunogenic, metabolically stable, and longer-circulating in vivo
CN101511390B (zh) 制备胰岛素样生长因子-1与聚(乙二醇)的偶联物的方法
RU2009134725A (ru) Варианты трансглутаминазы с улучшенной специфичностью
CN105451755A (zh) 铁调素类似物和其用途
NZ510529A (en) Peptides that have thrombopoietic activity used to increase the production of platelets or platelet precursors
JP2014519852A5 (https=)
CA2676797A1 (en) Novel macromolecule transduction domains and methods for identification and uses thereof
PT99565B (pt) Processo para a preparacao de factores de crescimento de fibroblastos quimerico s
CA2337100A1 (en) Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same
AU2008211884A1 (en) Novel polypeptide having anti-tumor activity
US5854025A (en) IGF-II analogues
CN1500095B (zh) 神经胚活素的多聚体偶联物及其应用方法
CN116789801B (zh) 新型胰岛素衍生物及其用途
WO2020073825A1 (zh) 一种改善生物活性蛋白性质的载体蛋白
RU2003105897A (ru) Белки урокортина и их применения
US20080200378A1 (en) KGF polypeptide compositions
JPWO2021229076A5 (https=)
DE602005025141D1 (de) In Zellen eindringende Peptide als Träger für Moleküle
US20110071077A1 (en) Thrombopoietic Compounds
JPH10338700A (ja) 新規ペプチド化合物
TW202038997A (zh) 胜肽之血中動態改善方法
KR102166543B1 (ko) 켈로이드 억제용 조성물 및 그 억제 방법
AU2002326742A1 (en) KGF polypeptide compositions